Quarterly Call Option Transactions in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during . The information is specifically focused on institutions that hold call options of EAGLE PHARMACEUTICALS, INC..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 0 | 23,626 | 23,626 | — | 23,626 | |||
Q4 2021 | — | 18,700 | 0 | 18,700 | -18,700 | |||
Q1 2022 | — | — | 0 | |||||
Q2 2022 | — | — | 0 | |||||
Q3 2022 | 0 | 174,500 | 174,500 | — | 174,500 | |||
Q4 2022 | — | 80,800 | 0 | 80,800 | -80,800 | |||
Q1 2023 | — | 58,400 | 0 | 58,400 | -58,400 | |||
Q2 2023 | 1,200 | 0 | 1,200 | — | 1,200 | |||
Q3 2023 | — | 1,500 | 0 | 1,500 | -1,500 | |||
Q4 2023 | 3,600 | 87,500 | 91,100 | — | 91,100 | |||
Q1 2024 | — | 2,000 | 0 | 2,000 | -2,000 | |||
Q2 2024 | 0 | 1,010,400 | 1,010,400 | — | 1,010,400 | |||
Q3 2024 | 0 | 900 | 900 | — | 900 |